Aquestive Therapeutics AQST
NASDAQ AQST
$4.55 +0.11 (+2.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aquestive Therapeutics (AQST) Depreciation & Amortization (CF) (2017 - 2026)

Updated

Aquestive Therapeutics (AQST) posted Depreciation & Amortization (CF) of $136,000 for Q2 2026, down 2.9% from $140,000 a year earlier but up 20.4% from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Aquestive Therapeutics was $518,000, down 11.5% year-over-year; for FY2025, it came in at $548,000, down 23.7% from FY2024.

  • Annual Depreciation & Amortization (CF) has declined for five consecutive years, with a five-year compound annual growth rate of -30.8% (FY2020 to FY2025).
  • In prior years, Aquestive Therapeutics' Depreciation & Amortization (CF) was $718,000 in FY2024 (-46.6%), $1.35 million in FY2023 (-43.7%), $2.39 million in FY2022 (-19.5%) and $2.96 million in FY2021 (-13.9%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $113,000 in Q1 2026 to a high of $736,000 in Q3 2021 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last ten quarters, with an average decline of 27.3% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2023, with growth of 17.6%; the weakest was Q4 2024, with a decline of 68.5%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $113,000 (Q1 2026), $130,000 (Q4 2025) and $139,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Aquestive Therapeutics 557.27 Mn 97.82 Mn 9.80 Mn 136,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 136,000.00
Mar 31, 2026 113,000.00
Dec 31, 2025 130,000.00
Sep 30, 2025 139,000.00
Jun 30, 2025 140,000.00
Mar 31, 2025 139,000.00
Dec 31, 2024 147,000.00
Sep 30, 2024 159,000.00
Jun 30, 2024 205,000.00
Mar 31, 2024 207,000.00
Dec 31, 2023 467,000.00
Sep 30, 2023 264,000.00
Jun 30, 2023 289,000.00
Mar 31, 2023 325,000.00
Dec 31, 2022 397,000.00
Sep 30, 2022 596,000.00
Jun 30, 2022 667,000.00
Mar 31, 2022 727,000.00
Dec 31, 2021 731,000.00
Sep 30, 2021 736,000.00
API Access

Aquestive Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=AQST&period=max&api_key=YOUR_API_KEY